Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Delft University of Technology (TU Delft)
- Eindhoven University of Technology (TU/e)
- University of Amsterdam (UvA)
- Utrecht University
- Amsterdam UMC
- University of Twente (UT)
- Wageningen University & Research
- Radboud University
- University of Twente
- Vrije Universiteit Amsterdam (VU)
- Maastricht University (UM)
- University of Groningen
- KNAW
- Sanquin Blood Supply Foundation (Sanquin)
- University Medical Center Utrecht (UMC Utrecht)
- ARCNL
- Centrum Wiskunde en Informatica (CWI)
- DIFFER
- Erasmus University Rotterdam
- HFML-FELIX
- Hotelschool The Hague
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- The Open Universiteit (OU)
- Tilburg University
- University Medical Centre Groningen (UMCG)
- 15 more »
- « less
-
Field
-
cross-sector design that also covers law enforcement, public transport and retail. The mechanisms which are investigated (vulnerability, motives for aggression, coercion and ethics of monitoring
-
programming (Matlab and/or Python); Hands on with laboratory work, skilled in experimental design; Creativity, assertive attitude, and perseverance The selection process will start immediately; the intended
-
include: designing and conducting proteomics experiments within the META-IMMUNOTYPES project; analysing plasma proteomics together with immune monitoring, metabolomics and flow cytometry datasets
-
will inform (1) the design of landers for future missions, and (2) the scientific interpretation of future mission data, by linking measured surface properties to processes such as resurfacing and
-
suspension pipe flow by 30–40% across different flow rates. This makes designing and controlling these flows difficult. The difficulty arises partly because these flows do not fit the conventional ‘laminar
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical